Heartflow, Inc. filings document a Nasdaq-listed Delaware medical technology company focused on AI software for coronary artery disease. Its recent 8-K reports furnish operating results, investor presentations and Regulation FD disclosures, while also recording capital-structure events tied to its completed initial public offering and repayment and termination of a credit agreement.
The company’s proxy materials cover annual meeting matters, director elections, auditor ratification and stockholder voting mechanics. As an emerging growth company, Heartflow’s filings also identify governance, exchange listing, financial reporting and public-company status disclosure areas relevant to a commercial-stage medical technology issuer.
Heartflow, Inc. (HTFL) reports a Rule 144 notice for John C.M. Farquhar, identified as an officer and director, covering a proposed sale of 38,900 common shares with an aggregate market value of $1,928,195.20. The notice lists October 12, 2026, as the approximate sale date, Fidelity Brokerage Services LLC as broker, and NASDAQ as the exchange.
Heartflow, Inc. (HTFL) reported that Chief Medical Officer Campbell Rogers exercised stock options for 13,179 shares of common stock on September 18, 2026 at exercise prices of $8.33 and $2.22 per share and sold 19,682 shares at $50.15 per share, all effected under a Rule 10b5-1 trading plan adopted on June 16, 2026.
After these transactions, Rogers continued to hold shares indirectly through several personal and family trusts, including 22,615, 46,159, 26,012 and 50,754 shares in separate trust accounts.
Heartflow, Inc. (HTFL) reported that its Chief Financial Officer, Vikram Verghese, sold shares of common stock in two open-market transactions made under a Rule 10b5-1 trading plan adopted on June 4, 2026. On September 17, 2026 he sold 7,579 shares at a weighted average price of $50.1142 per share, and on September 18, 2026 he sold 16,766 shares at a weighted average price of $50.7531, each sale executed in multiple trades within stated price ranges.
Heartflow, Inc. (HTFL) has an officer, Vikram Verghese, filing a Rule 144 notice to sell up to 16,766 shares of common stock through Fidelity Brokerage Services LLC. The shares have an aggregate market value of $850,926.94 based on prices as of September 18, 2026 on NASDAQ.
The shares to be sold were acquired from the issuer via stock option exercises on June 10, 2024 (9,629 shares) and September 30, 2024 (7,137 shares), both paid in cash. The notice also lists several prior common stock sales by Verghese during the past three months.
Heartflow, Inc. (HTFL) received a notice under Rule 144 that Campbell D. Rogers, an officer of the company, has filed to sell 5,653 shares of common stock, held at Fidelity Brokerage Services LLC. These shares relate to a stock option exercise on March 21, 2018.
The filing also reports that Campbell D. Rogers sold 9,219 shares of Heartflow common stock on July 15, 2026 for $237,112.68 and another 9,219 shares on September 18, 2026 for $380,099.37. The September 18 trade occurred in the Sarah Rogers Ttee Campbell Rogers 2019 Irrevocable Trust, for which Sarah D. Rogers, the officer’s spouse, is a trustee.
Heartflow, Inc. (HTFL) discloses that officer Campbell D. Rogers plans to sell 19,682 shares of Common Stock under Rule 144, sourced from stock option exercises dated March 1, 2021 and September 18, 2026. Recent sales over the prior three months totaled 18,438 shares for $617,212.05. Today’s planned sale includes 6,503 shares held by the Sarah Rogers 2020 Irrevocable Trust, for which Campbell D. Rogers serves as trustee and account stakeholder.
Heartflow, Inc. (HTFL) received a notice that stockholder Vikram Verghese plans to sell up to 7,579 shares of common stock in a proposed public sale under Rule 144 through Fidelity Brokerage Services LLC. The shares relate to a stock option exercise on June 10, 2024 for cash from the issuer.
The notice also lists prior open-market sales by Vikram Verghese during the past three months, including multiple transactions in common stock with stated share counts and dollar amounts.
Heartflow, Inc. (HTFL) reported that its Chief Financial Officer, Vikram Verghese, sold a total of 34,975 shares of common stock in three open-market transactions on September 11, 14, and 15, 2026, at weighted average prices around $50 per share. All transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on June 4, 2026, and each trade was executed in multiple lots within the disclosed price ranges.
Heartflow, Inc. (HTFL) received a notice under Rule 144 from officer Vikram Verghese for a proposed sale of up to 668 shares of common stock through Fidelity Brokerage Services LLC. The shares relate to a stock option exercise on June 10, 2024 and have an aggregate market value of $33,408.00 as of September 15, 2026. The notice also lists several prior open‑market sales of Heartflow common stock by Verghese during the preceding three months.
Heartflow, Inc. (HTFL) Chief Executive Officer and director John C.M. Farquhar reported the sale of a total of 38,900 shares of common stock in two open-market transactions on September 10 and 11, 2026. These sales were effected pursuant to a Rule 10b5-1 trading plan adopted on September 12, 2025, including one trade executed in multiple transactions within a disclosed price range.